Godavari Biorefineries Limited (NSE: GODAVARIB, BSE: 544279) has disclosed receiving an income tax demand of ₹46.15 crore (including interest) from the Assessment Unit of the Income Tax Department under Section 143(3) read with Section 144B of the Income Tax Act, 1961. The demand pertains to the company’s income tax return filed for the financial year 2022-23.
The assessment order, dated March 24, 2025, includes certain additions and disallowances made by the Assessing Officer with respect to the returned income of the company.
Godavari Biorefineries has stated that it believes the demand is not maintainable and is in the process of filing an appeal, rectification application, and a stay order against the said demand. The company has assured stakeholders that there will be no immediate impact on its financials, operations, or other activities due to this development.
Manoj Jain, Company Secretary & Compliance Officer of Godavari Biorefineries Limited, confirmed these developments in a regulatory filing with stock exchanges.
Disclaimer: The information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.
Also read: TVS Holdings Declares ₹93 Interim Dividend Per Share for FY25
Published on: March 24, 2025 at 8.15PM GMT.
Sourcex India 2025 Trade Event Commences in New Delhi
Sourcex India 2025, a prominent international trade event, begins today at the Yashobhoomi Convention Centre in Dwarka, New Delhi. The three-day event aims to showcase India’s export potential, featuring over 150 foreign buyers from more than 45 countries. It serves as a vital platform for Indian exporters to engage with global markets.
As stated in Bhagavad Gita :
एष तेऽभिहितः सांख्ययोगः।
The one who does not follow the wheel of creation set of going in this world, sinful and sensual, lives in pain.
